FOR MELAS: Khondrion Receives Rare Pediatric Disease Designation for Sonlicromanol from US FDA Designation granted for the treatment of MELAS ( mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes) syndrome NIJMEGEN, the Netherlands – Monday, September 28, 2020: Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease, today announces […]